Development of Microemulsion Based Nabumetone Transdermal Delivery For Treatment of Arthritis.

Conclusion Nabumetone microemulgel exhibiting good in-vitro and ex-vivo controlled drug release was optimized.
PMID: 29485013 [PubMed - as supplied by publisher]

Source: Recent Patents on Drug Delivery and Formulation - March 1, 2018 Category: Drugs & Pharmacology Tags: Recent Pat Drug Deliv Formul Source Type: research